Towards efficient drug development modelling with machine learning.

1) Brief description of the context of the research including potential impact:
Despite significant investment, a substantial proportion of Phase III drug trials fail, contributing to delays, rising costs and unmet medical needs. One of the key challenges is accurately predicting drug effects during development, particularly in pharmacokinetics…